COVID-19 infection COVID-19 infection
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Subjects whose age at the time of obtaining consent is more than 20 years (2) Sex; female (3) quarantine at the hotel (4) Meets all of 1)-3) below 1) Subjects whose Asymptomatic/mild case (without respiratory sympton nor dyspnea) has at least one RT-PCR test positive for SARS-CoV-2 from pharyng eal swab, nasopharyng eal swab or saliva. 2) Subjects who can gargle 3) Subjects who are on the first day of admission to the accommodation treatment facility and plan to perform accommodation treatment for 6 days or more (5) Subjects who have obtained written consent voluntarily to participate in the trial
Exclusion criteria
Exclusion criteria: Garg ling with sodium lauryl diethylendiaminoglycine before entry
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The amount of virus excreted from the oral cavity by gargling is measured, and the virus removal effect from the oral cavity by gargling is confirmed. Also, evaluate the difference from water gargling. | — |
Secondary
| Measure | Time frame |
|---|---|
| The amount of virus in saliva after gargling is measured, and the effect of gargling on reducing viral shedding in saliva is evaluated. | — |
Contacts
Osaka Habikino Medical Center, Osaka Prefectural Hospital Organization